SCHEMBL28713773

SCHEMBL28713773

Cc1cc(Br)ccc1C(=O)NC[C@H](C)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ FLT1 P17948 1/20 0.39
▸ FLT4 P35916 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ APLNR P35414 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ HPGD P15428 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ FOLH1 Q04609 1/20 0.37
▸ AAK1 Q2M2I8 2/20 0.37
▸ TP53 P04637 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ SORT1 Q99523 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22858947 1.00 TRPV1 (0.40) TRPV1ALDH1A1KDM4EFLT1FLT4
SCHEMBL22859168 1.00 TRPV1 (0.40) TRPV1ALDH1A1KDM4EFLT1FLT4
SCHEMBL22858693 0.86 ALDH1A1 (0.48) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL28507569 0.86 ALDH1A1 (0.48) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL28507567 0.86 ALDH1A1 (0.48) ALDH1A1KDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL22859172 0.79 FLT1 (0.46) TRPV1ALDH1A1KDM4EFLT1FLT4
SCHEMBL22859142 0.79 FLT1 (0.46) TRPV1ALDH1A1KDM4EFLT1FLT4
SCHEMBL22859136 0.79 FLT1 (0.46) TRPV1ALDH1A1KDM4EFLT1FLT4
SCHEMBL22858696 0.79 APLNR (0.38) TRPV1ALDH1A1FLT1FLT4KDR
SCHEMBL22858704 0.79 APLNR (0.38) TRPV1ALDH1A1FLT1FLT4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12454534-B2 Pyrrolo[2,3-b]pyrazines as HPK1 inhibitor and the use thereof BEONE MEDICINES I GMBH (CH) 2025-10-28 — — US disclosed
CN-115073474-B Pyrrolo [2,3-b ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2024-10-18 — — CN disclosed
CN-115073474-A Pyrrolo [2,3-b ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2022-09-20 — — CN disclosed
CN-115028639-A Pyrrolo [2,3-b ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2022-09-09 — — CN disclosed
US-20220267333-A1 PYRROLO[2,3-b]PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF BEONE MEDICINES I GMBH (CH) 2022-08-25 — — US disclosed
EP-3994136-A1 PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF BeiGene, Ltd. (KY) 2022-05-11 — — EP disclosed
CN-114096536-A Pyrrolo [2,3-b ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2022-02-25 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220267333-A1 PYRROLO[2,3-b]PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF PDXK, STK25, STK35 TRPV1 2504/4885ALDH1A1 3320/4885KDM4E 3177/4885
US-12454534-B2 Pyrrolo[2,3-b]pyrazines as HPK1 inhibitor and the use thereof PDXK, STK25, STK35 TRPV1 2504/4885ALDH1A1 3320/4885KDM4E 3177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback